Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I-II Study to Assess the Safety, Tolerability and Efficacy of PM01183 and Atezolizumab in Patients With Advanced Small Cell Lung Cancer That Progressed Following Prior Therapy With Platinum-Based Chemotherapy.

NCT04253145 is registered in ClinicalTrials.gov with Fundacion Oncosur as lead sponsor.

NCT NCT04253145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04253145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I-II Study to Assess the Safety, Tolerability and Efficacy of PM01183 and Atezolizumab in Patients With Advanced Small Cell Lung Cancer That Progressed Following Prior Therapy With Platinum-Based Chemotherapy.
Lead sponsor
Fundacion Oncosur
Phase
Phase 1/2
Overall status
Unknown status
Start date
December 13, 2019
Completion date
May 31, 2025
Enrollment
184 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, small cell lung